# US Cardiac Implants Market > US Cardiac Implants Market Research Report By Device (Coronary Stents, Prosthetic Heart Valve Devices, Others), By Indication (Arrhythmias, Heart Failure, Others) and By End User (Hospitals, Cardiac Care Centers, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.92% - **2024:** $ 11.5 Billion - **2025:** $ 12.3 Billion - **2035:** $ 24 Billion - **Key Players:** Medtronic (US), Abbott (US), Boston Scientific (US), Edwards Lifesciences (US), Biotronik (DE), LivaNova (GB), St. Jude Medical (US), Terumo (JP), Cardiac Science (US) **Report ID:** MRFR/MED/51271-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** August 07, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-cardiac-implants-market-53032 --- ## Market Summary ## **US Cardiac Implants Market Overview** As per MRFR analysis, the US Cardiac Implants Market Size was estimated at 9.88 (USD Billion) in 2023.The US Cardiac Implants Market Industry is expected to grow from 10.9(USD Billion) in 2024 to 30.8 (USD Billion) by 2035. The US Cardiac Implants Market CAGR (growth rate) is expected to be around 9.903% during the forecast period (2025 - 2035) ## **Key US Cardiac Implants Market Trends Highlighted** The US Cardiac Implants Market is seeing several notable trends. One key driver is the increasing prevalence of cardiovascular diseases, which has led to a higher demand for cardiac implants such as pacemakers and defibrillators. With a growing aging population in the US, more individuals are requiring advanced cardiac care. Technological advancements play a significant role, with innovations such as leadless pacemakers and remote monitoring devices enhancing patient outcomes and driving market growth.  Additionally, healthcare policies that emphasize preventive care and the treatment of chronic diseases are providing further impetus to the cardiac implants market. Integrated healthcare systems in the US are shifting towards improved patient management, fostering opportunities for manufacturers to develop new cardiac technologies. The market also benefits from the rising awareness and accessibility of heart disease management programs, leading to increased diagnosis and treatment rates.Recent trends include a focus on minimally invasive procedures, which not only reduce recovery time for patients but also lower the overall risks associated with surgery. The growth of outpatient procedures in the US healthcare system further highlights a preference for streamlined and efficient cardiac care solutions. Digital health integration is also becoming important, with telemedicine expanding access to cardiac specialists, thereby supporting the use of cardiac implants. Together, these factors indicate a dynamic landscape in the US Cardiac Implants Market, where innovation meets the pressing needs of a population grappling with cardiac health issues. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Cardiac Implants Market Drivers** ### **Rising Incidence of Cardiovascular Diseases** The growing prevalence of cardiovascular diseases (CVD), which continues to be the major cause of death in the United States, drives the US Cardiac Implants Market. According to the American Heart Association, about 697,000 individuals died from cardiovascular disease in the United States in 2020, accounting for around one out of every five fatalities. This worrying incidence increases demand for cardiac implants such as pacemakers and stents as patients seek sophisticated medical procedures. Furthermore, rising knowledge of early detection and treatment options has led to an increase in cardiac surgeries, boosting market development possibilities. Major healthcare organizations, including as the American College of Cardiology and the American Heart Association, are actively pushing awareness campaigns, which contribute to increased diagnosis rates and drive demand in the US Cardiac Implants Market Industry. The market is expected to develop significantly as a result of an increasing emphasis on Research and Development (R&D) to innovate and improve cardiac implant technology. ### **Technological Advancements in Cardiac Devices** The US Cardiac Implants Market Industry is significantly influenced by rapid technological advancements in cardiac devices. Innovations such as minimally invasive procedures, remote monitoring, and advanced imaging technologies are enhancing the effectiveness of cardiac implants. The US Food and Drug Administration (FDA) has introduced streamlined processes for approving innovative devices, paving the way for quicker access to cutting-edge technologies. Recent advancements have shown that catheter-based heart valve therapies can reduce recovery times and improve outcomes for patients with severe cardiovascular conditions. Leading companies such as Medtronic and Boston Scientific are at the forefront of these innovations, continuously expanding their portfolios with advanced cardiac implant solutions, thus driving the growth of the market. ### **Aging Population and Increased Healthcare Expenditure** The demographic shift towards an aging population in the United States significantly fuels the growth of the US Cardiac Implants Market Industry. According to the United States Census Bureau, the population aged 65 years and older is projected to reach 77 million by 2034, leading to a higher demand for cardiac care due to age-related comorbidities. Older adults are more susceptible to heart conditions, thus driving the need for cardiac implants such as defibrillators and pacemakers. Moreover, increasing healthcare expenditure is crucial, with the Centers for Medicare and Medicaid Services estimating a rise in national health spending, projected to reach 20.1% of the Gross Domestic Product by 2028. This commitment to improving healthcare access and resources directly supports the adoption of cardiac implants across the nation. ## **US Cardiac Implants Market Segment Insights** ### **Cardiac Implants Market Device Insights  ** The Device segment of the US Cardiac Implants Market represents a crucial part of the healthcare ecosystem, focusing on advanced therapeutic interventions for cardiovascular conditions. This segment encompasses various types of medical devices designed to treat heart-related ailments, including Coronary Stents, Prosthetic Heart Valve Devices, and other innovative solutions. Coronary Stents have emerged as a pivotal innovation in the treatment of coronary artery disease, helping to restore blood flow by keeping arteries open. Their design and material technology have evolved significantly, allowing for the development of drug-eluting stents that minimize the risk of re-occlusion, thus enhancing patient outcomes. Meanwhile, Prosthetic Heart Valve Devices play an equally vital role, especially with a growing aging population in the US that increasingly requires valve replacement surgeries. These devices must meet stringent regulatory requirements to ensure safety and effectiveness, which drives continuous research and advancements in biocompatible materials and minimally invasive surgical techniques. Other innovations within this segment encompass a variety of devices aimed at treating diverse cardiac conditions, including implantable cardioverter-defibrillators and cardiac resynchronization therapy, further underscoring the segment's breadth. The growing prevalence of cardiovascular diseases in the US, complemented by increasing awareness and advancements in technology, has created a favorable landscape for market growth. Technological advancements such as bioresorbable stents and transcatheter valve replacements continue to unfold, presenting new opportunities for manufacturers to cater to diverse medical needs. Collectively, these devices contribute significantly to improving the quality of life for patients while addressing substantial economic costs associated with cardiovascular diseases in the US healthcare system. As healthcare continues to evolve, the Device segment remains a focal point for ongoing investment and innovation, bolstered by favorable regulatory environments and an emphasis on patient-centered care methodologies. Overall, the dynamics within this segment reflect the critical need for innovative, effective solutions amid the rising incidence of heart conditions across the United States. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Cardiac Implants Market Indication Insights  ** The US Cardiac Implants Market is prominently segmented based on Indication, which plays a vital role in addressing various cardiovascular conditions. A significant portion of the market is dedicated to addressing Arrhythmias, conditions that disrupt the normal rhythm of the heart, thereby requiring advanced implantable devices for effective management and treatment. Heart Failure also constitutes a crucial area within the market, as millions of Americans grapple with this chronic condition, necessitating the use of cardiac implants to enhance quality of life and reduce mortality rates. The Others category encompasses a variety of cardiovascular issues that are also managed through implantable devices, showcasing the versatility and adaptability of cardiac technologies. With an increasing prevalence of heart-related diseases in the US population, advancements in implant technology and ongoing Research and Development efforts are expected to drive growth in these segments, presenting an opportunity for innovation and improved patient outcomes. As the market evolves, understanding these indications will be essential for stakeholders aiming to tailor solutions that meet the specific needs of diverse patient populations, thus enhancing the overall efficacy of the US Cardiac Implants Market industry. ### **Cardiac Implants Market End User Insights  ** The US Cardiac Implants Market exhibits significant opportunity across its End User segment, which includes Hospitals, Cardiac Care Centers, and other healthcare facilities. Hospitals hold a major share, being critical in providing comprehensive cardiac care and surgical interventions that cater to various patient needs. Cardiac Care Centers have emerged as specialized facilities focused on advanced diagnostics and treatment options specifically for cardiac patients, offering tailored care that supports recovery and improves patient outcomes. The demand for these centers has grown as more patients require specialized attention due to the rising prevalence of cardiovascular diseases. Additionally, other healthcare entities, such as outpatient clinics, play an essential role in delivering cardiac implant services, emphasizing the diversified nature of the market. With an aging population and increasing awareness about heart health, the US faces a robust increase in the need for cardiac implants, driving growth across these End User categories. The importance of these facilities is heightened by the expanding advancements in medical technology, providing innovative solutions that support effective cardiac care. Overall, the segmentation of the US Cardiac Implants Market by End User underscores the strategic relevance of tailored healthcare solutions in enhancing patient outcomes. ## **US Cardiac Implants Market Key Players and Competitive Insights** The US Cardiac Implants Market is characterized by a blend of innovation, competition, and rapid technological advancements, catering to a growing clientele with cardiovascular issues. With an increasing prevalence of heart diseases in the region, the market has attracted a multitude of players, each vying for a significant share through differentiated products and services. The competitive landscape features established companies along with emerging startups that are focused on developing unique solutions to improve patient outcomes. Companies in this market leverage advanced technologies, strategic partnerships, and extensive research initiatives to enhance their product portfolios and reinforce their market positions. Additionally, regulatory approvals and the ability to navigate complex healthcare systems play critical roles in determining the success of these companies in a highly competitive environment. AtriCure is recognized as a prominent player in the US Cardiac Implants Market, primarily focusing on providing innovative surgical devices to treat atrial fibrillation and related conditions. The company enjoys a strong market presence due to its commitment to research and development, evidenced by a robust pipeline of advanced therapeutic solutions that address both surgical and procedural challenges in cardiac care. AtriCure's strengths are manifested through its advanced technologies and a comprehensive suite of products, including energy-based surgical devices that have gained traction among healthcare professionals for their efficacy and safety. The company's investment in clinical studies and collaborations with leading cardiology experts further solidifies its position as a trusted developer of cardiac implant solutions. As they continue to expand their offerings, AtriCure engages in strategic initiatives to enhance their market penetration while addressing the specific needs of healthcare providers and patients within the US. Gore Medical also commands a significant presence in the US Cardiac Implants Market, known for its extensive portfolio of innovative products aimed at various cardiovascular applications. The company’s key offerings include vascular grafts and stent technologies that have proven effective and reliable for patients undergoing cardiac procedures. Gore Medical has developed a strong reputation for quality and safety, which contributes to its competitive advantage in the market. The firm focuses on continuous improvement through technological advancements and has successfully undergone a series of strategic mergers and acquisitions to bolster its product offerings and expand its market footprint. This focus allows Gore Medical to maintain a stronghold on innovation, enabling healthcare providers to access cutting-edge solutions that cater to complex cardiovascular conditions. As the market evolves, Gore Medical’s dedicated approach to physician collaboration and patient-centric product development positions it favorably among its competitors in the US Cardiac Implants Market. ### **Key Companies in the US Cardiac Implants Market Include** - AtriCure - Gore Medical - Abbott Laboratories - Edwards Lifesciences - Boston Scientific - LivaNova - Terumo Holdings - Jude Medical - Getinge - Johnson & Johnson - AngioDynamics - Medtronic - [Biotronik](https://www.biotronik.com/en-int/patients/patients-and-caregivers/therapies/cardiac-resynchronization-therapy) - Coherus Biosciences - Sorin Group ## **US Cardiac Implants Market Industry Developments** The US Cardiac Implants Market has witnessed significant developments recently, particularly regarding innovations and regulatory approvals. AtriCure announced in August 2023 the launch of its next-generation atrial fibrillation management device, which aims to enhance patient outcomes. Abbott Laboratories has been expanding its product portfolio with breakthroughs in transcatheter heart valve technologies, reflecting a growing focus on minimally invasive options. In terms of market dynamics, Edwards Lifesciences reported a robust growth in its heart valve business, driven by increasing adoption in clinical settings. Regarding mergers and acquisitions, Boston Scientific completed its acquisition of a leading cardiac rhythm management company in September 2023, aiming to expand its footprint in the electrophysiology market. Johnson and Johnson also announced plans to acquire a cardiovascular device company, further consolidating its position in this sector. The US cardiac implants market has experienced strong valuation growth, with Medtronic's recent investments in Research and Development significantly contributing to its market share. Additionally, over the past few years, interest in innovative cardiac procedures has surged, leading to patient acceptance and enhanced clinical outcomes, solidifying the US market's leadership globally. ## **Cardiac Implants Market Segmentation Insights** ### **Cardiac Implants Market Device Outlook** - Coronary Stents - Prosthetic Heart Valve Devices - Others ### **Cardiac Implants Market Indication Outlook** - Arrhythmias - Heart Failure - Others  ### **Cardiac Implants Market End User Outlook** - Hospitals - Cardiac Care Centers - Others ## Market Drivers ### Increased Healthcare Expenditure The rising healthcare expenditure in the US is significantly impacting the cardiac implants market. With healthcare spending projected to reach $6 trillion by 2027, there is a growing investment in advanced medical technologies, including cardiac implants. This increase in funding allows for the development and adoption of innovative devices that can improve patient outcomes. Additionally, as more patients gain access to health insurance, the demand for cardiac procedures is likely to rise. The cardiac implants market is expected to benefit from this trend, as healthcare providers seek to offer cutting-edge solutions to meet the needs of their patients. Furthermore, the emphasis on value-based care is encouraging hospitals to invest in high-quality implants that can lead to better long-term health outcomes, thereby driving market growth. ### Aging Population and Lifestyle Changes The aging population in the US, coupled with lifestyle changes, is a significant driver of the cardiac implants market. As individuals age, the risk of developing cardiovascular diseases increases, leading to a higher demand for cardiac interventions. The US Census Bureau projects that by 2030, all baby boomers will be over 65 years old, resulting in a substantial increase in the elderly population. Concurrently, lifestyle factors such as poor diet, lack of exercise, and increased stress levels contribute to the prevalence of heart-related conditions. This demographic shift is likely to create a greater need for cardiac implants, as healthcare providers seek to address the growing burden of cardiovascular diseases. The cardiac implants market is poised for growth, with estimates suggesting a potential market size of $45 billion by 2026, driven by these demographic and lifestyle trends. ### Enhanced Patient Awareness and Education Enhanced patient awareness and education regarding cardiovascular health are emerging as vital drivers of the cardiac implants market. As patients become more informed about the risks associated with heart disease and the available treatment options, they are more likely to seek medical intervention. Initiatives by healthcare organizations and advocacy groups are promoting awareness campaigns that educate the public about the importance of early detection and treatment of cardiovascular conditions. This increased awareness is likely to lead to higher rates of diagnosis and, consequently, a greater demand for cardiac implants. The cardiac implants market is expected to benefit from this trend, as more patients actively engage in their healthcare decisions. Furthermore, the emphasis on shared decision-making between patients and healthcare providers may result in a more tailored approach to treatment, further driving the adoption of cardiac implants. ### Technological Innovations in Implant Design Technological advancements in the design and functionality of cardiac implants are transforming the landscape of the cardiac implants market. Innovations such as bioresorbable stents, advanced pacemakers, and implantable cardioverter-defibrillators (ICDs) are enhancing patient outcomes and driving market growth. The integration of smart technology into these devices allows for real-time monitoring and data collection, which can lead to improved patient management. Furthermore, the development of minimally invasive surgical techniques is reducing recovery times and hospital stays, making these procedures more appealing to patients. As a result, the cardiac implants market is experiencing a surge in demand, with projections indicating a market value exceeding $50 billion by 2027. This trend suggests that ongoing research and development will continue to play a crucial role in shaping the future of cardiac care. ### Rising Prevalence of Cardiovascular Diseases The increasing incidence of cardiovascular diseases in the US is a primary driver for the cardiac implants market. According to the CDC, heart disease remains the leading cause of death, accounting for approximately 697,000 deaths annually. This alarming statistic underscores the urgent need for effective treatment options, including cardiac implants. As the population ages, the prevalence of conditions such as coronary artery disease and heart failure is expected to rise, further propelling demand for innovative cardiac devices. the cardiac implants market is projected to grow significantly, with estimates suggesting a compound annual growth rate (CAGR) of around 6.92% over the next several years. This growth is likely to be fueled by advancements in implant technology and increased awareness of treatment options among healthcare providers and patients alike. ## Future Outlook The [Cardiac Implants Market](https://www.marketresearchfuture.com/reports/cardiac-implants-market-6726) is projected to grow at a 6.92% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of cardiovascular diseases, and rising healthcare expenditure. **New opportunities:** - Development of AI-driven predictive analytics for patient monitoring. Expansion of telehealth services for remote cardiac care. Investment in biodegradable implant materials for sustainability. By 2035, the cardiac implants market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Indication: Heart Failure (Largest) vs. Arrhythmias (Fastest-Growing) In the US cardiac implants market, the indication segment is primarily dominated by Heart Failure, representing the largest share due to the increasing prevalence of heart failure cases among the aging population. Arrhythmias have also gained significant traction, positioning themselves as a critical area of focus for innovation. Furthermore, other segments such as Myocardial Ischemia and Acute Myocardial Infarction hold relevance but lag behind in terms of overall market share distribution, indicating a shift towards advanced solutions for more complex conditions. Growth trends in the indication segment are being driven by advancements in technology and an increased understanding of heart disease. The rising demand for minimally invasive surgical techniques and implantable devices is fueling the growth of segments like Arrhythmias, characterized by technological innovation. Additionally, the aging population and the corresponding rise in chronic heart issues are propelling the demand for cardiac implants, particularly in the Heart Failure category, indicating a robust growth trajectory for the future. Heart Failure (Dominant) vs. Arrhythmias (Emerging) Heart Failure is recognized as the dominant segment within the US cardiac implants market, largely due to its growing patient base and the increasing need for effective management solutions. The complexity of heart failure cases has driven demand for sophisticated and reliable implantable devices, enhancing patient outcomes significantly. In contrast, Arrhythmias is emerging rapidly as a segment, fueled by innovations in implantable devices designed for continuous monitoring and management of heart rhythms. This segment focuses on addressing conditions that can lead to serious complications, making it a crucial area for growth and development. Both segments are essential, with Heart Failure leading in market share while Arrhythmias is on a fast track to capture a larger market presence through technological advancements. ### By Device: Implantable Loop Recorder (Largest) vs. Cardiac Rhythm Management Devices (Fastest-Growing) In the US cardiac implants market, the segment values exhibit distinct market share distribution, with the Implantable Loop Recorder commanding a significant share due to its effectiveness in monitoring heart rhythms. Cardiac Rhythm Management Devices, while smaller in share, are experiencing rapid adoption fueled by technological advancements and increasing patient awareness around cardiac health. The remaining segment values, including Coronary Stents and Ventricular Assist Devices, also contribute valuable shares but do not match the prominence of these two key players. Growth trends indicate that Cardiac Rhythm Management Devices are the fastest-growing segment, driven by innovations in device technology and rising incidences of cardiac diseases. Moreover, the emphasis on early diagnosis and preventive measures in healthcare is propelling demand. The Implantable Loop Recorder maintains a robust position, leveraging its accuracy and patient-centric benefits, while the overall segment anticipates further developments as healthcare systems evolve. Cardiac Rhythm Management Devices (Dominant) vs. Others (Emerging) Cardiac Rhythm Management Devices represent a dominant force within the US cardiac implants market, characterized by a comprehensive range of products including pacemakers and ICDs. Their effectiveness in managing arrhythmias and enhancing patient outcomes solidifies their market position. Conversely, the 'Others' category, which includes emerging technologies and novel implants, shows potential for growth as innovations continue to surface. These products cater to niche requirements and are gradually gaining traction among healthcare providers. As the market matures, the integration of advanced technology in the 'Others' segment is likely to attract interest, providing a complementary push to the established dominance of Cardiac Rhythm Management Devices. ### By End-User: Hospitals (Largest) vs. Ambulatory Centers (Fastest-Growing) In the US cardiac implants market, the segmentation by end-user reveals that hospitals are the largest recipients of cardiac implant devices, capturing a significant portion of the market share. This dominance is primarily due to hospitals' advanced capabilities, specialized personnel, and the comprehensive care they provide for cardiac procedures. In contrast, ambulatory centers are emerging as a formidable player in the market, attracting attention for their growing adoption of cardiac implants and expanding patient base. The growth trends in this segment indicate a shift towards more decentralized healthcare models, with ambulatory centers becoming increasingly popular due to their cost-effectiveness and shorter wait times. This shift is driven by advancements in technology that allow for outpatient procedures that were previously limited to hospital settings. Furthermore, an aging population and a rise in chronic cardiovascular diseases are fueling the demand for accessible care solutions, making ambulatory centers a key focus for future investments. Hospitals (Dominant) vs. Ambulatory Centers (Emerging) Hospitals remain the dominant players in the cardiac implants segment due to their comprehensive infrastructure, which includes specialized cardiac care units and advanced diagnostic and therapeutic technologies. Their ability to provide complex procedures and post-operative care ensures a steady demand for implants. On the other hand, ambulatory centers represent an emerging segment characterized by their focus on outpatient procedures. They are increasingly favored by patients seeking quicker recovery times and reduced hospitalization costs. The growth of ambulatory centers is supported by innovations in implant technologies that facilitate safe, effective procedures in less invasive settings, thereby reshaping how heart care is delivered. ## Competitive Benchmarking The cardiac implants market is characterized by a dynamic competitive landscape, driven by technological advancements, an aging population, and increasing prevalence of cardiovascular diseases. Major players such as Medtronic (US), Abbott (US), and Boston Scientific (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) focuses on innovation through extensive R&D investments, aiming to develop next-generation devices that improve patient outcomes. Abbott (US), on the other hand, emphasizes strategic partnerships and acquisitions to expand its product portfolio and market reach, while Boston Scientific (US) is leveraging digital transformation to enhance its operational efficiency and customer engagement, thereby shaping a competitive environment that prioritizes innovation and responsiveness.Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and innovations, fostering a competitive atmosphere where companies must continuously adapt to maintain their market positions. In October Medtronic (US) announced the launch of a new cardiac monitoring device designed to provide real-time data to healthcare providers. This strategic move is significant as it aligns with the growing trend towards remote patient monitoring, potentially improving patient management and outcomes. By investing in such technologies, Medtronic (US) reinforces its commitment to innovation and positions itself as a leader in the digital health space. In September Abbott (US) completed the acquisition of a smaller biotech firm specializing in advanced cardiac imaging technologies. This acquisition is pivotal as it not only expands Abbott's technological capabilities but also enhances its competitive edge in the cardiac diagnostics segment. The integration of advanced imaging solutions into Abbott's existing product line could lead to improved diagnostic accuracy and patient care, further solidifying its market position. In August Boston Scientific (US) launched a new line of biodegradable stents aimed at reducing long-term complications associated with traditional stents. This initiative reflects a growing trend towards sustainability in medical devices, appealing to both healthcare providers and patients. By prioritizing environmentally friendly solutions, Boston Scientific (US) differentiates itself in a crowded market, potentially attracting a new customer base focused on sustainability. As of November current trends in the cardiac implants market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into device functionality. Strategic alliances among key players are increasingly shaping the competitive landscape, fostering innovation and collaboration. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, enhanced patient outcomes, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge in the cardiac implants market. ## Recent News & Developments The US Cardiac Implants Market has witnessed significant developments recently, particularly regarding innovations and regulatory approvals. AtriCure announced in August 2023 the launch of its next-generation atrial fibrillation management device, which aims to enhance patient outcomes. Abbott Laboratories has been expanding its product portfolio with breakthroughs in transcatheter heart valve technologies, reflecting a growing focus on minimally invasive options. In terms of market dynamics, Edwards Lifesciences reported a robust growth in its heart valve business, driven by increasing adoption in clinical settings. Regarding mergers and acquisitions, Boston Scientific completed its acquisition of a leading cardiac rhythm management company in September 2023, aiming to expand its footprint in the electrophysiology market. Johnson and Johnson also announced plans to acquire a cardiovascular device company, further consolidating its position in this sector. The US cardiac implants market has experienced strong valuation growth, with Medtronic's recent investments in Research and Development significantly contributing to its market share. Additionally, over the past few years, interest in innovative cardiac procedures has surged, leading to patient acceptance and enhanced clinical outcomes, solidifying the US market's leadership globally. ## Report Scope | MARKET SIZE 2024 | 11.5(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 12.3(USD Billion) | | MARKET SIZE 2035 | 24.0(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.92% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Medtronic (US), Abbott (US), Boston Scientific (US), Edwards Lifesciences (US), Biotronik (DE), LivaNova (GB), St. Jude Medical (US), Terumo (JP), Cardiac Science (US) | | Segments Covered | Indication, Device, End-User | | Key Market Opportunities | Integration of advanced materials and digital health technologies in cardiac implants. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the cardiac implants market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US cardiac implants market in 2024?** A: The market valuation of the US cardiac implants market was $11.5 Billion in 2024. **Q: What is the projected market valuation for the US cardiac implants market by 2035?** A: The projected market valuation for the US cardiac implants market is $24.0 Billion by 2035. **Q: What is the expected CAGR for the US cardiac implants market during the forecast period 2025 - 2035?** A: The expected CAGR for the US cardiac implants market during the forecast period 2025 - 2035 is 6.92%. **Q: Which key players are leading the US cardiac implants market?** A: Key players in the US cardiac implants market include Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, and St. Jude Medical. **Q: What are the major segments of the US cardiac implants market?** A: The major segments of the US cardiac implants market include indications, devices, and end-users. **Q: What was the market size for arrhythmias in the US cardiac implants market in 2024?** A: The market size for arrhythmias in the US cardiac implants market was $2.3 Billion in 2024. **Q: What is the projected market size for heart failure devices by 2035?** A: The projected market size for heart failure devices is $6.5 Billion by 2035. **Q: How much is the market for cardiac rhythm management devices expected to grow by 2035?** A: The market for cardiac rhythm management devices is expected to grow to $8.0 Billion by 2035. **Q: What was the market size for hospitals as an end-user in 2024?** A: The market size for hospitals as an end-user in 2024 was $5.0 Billion. **Q: What is the projected market size for coronary stents by 2035?** A: The projected market size for coronary stents is $6.0 Billion by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-cardiac-implants-market-53032*